Hotline: new developments in TAVI

Presentations available when logged in:

• 30-day outcomes from an early feasibility study to assess the safety and effectiveness of a novel transfemoral TAVR system for the treatment of pat...
• TAVR with a supra-annular, self-expanding valve in patients at low risk of mortality following surgery
• 30-day outcomes following TAVI with a supra-annular self-expanding valve with pericardial wrap: primary results from the FORWARDPRO study
• Acute outcomes of a novel transcatheter heart valve to treat degenerated surgical valves - The VIVALL multicentre, single-arm, pilot study
• Safety, feasibility and acute performance of the Leaflex Performer when used pre-TAVI in aortic stenosis patients - The Leaflex Performer feasibili...
• One-year clinical outcomes of India's first indigenously designed and manufactured TAVR system
• Clinical outcomes of the Portico transcatheter aortic valve delivered via alternative access: 30-day results of the Portico ALT study